G01N 2800/048
Pituitary or hypothalamic - pituitary relationships
Official title: Pituitary or hypothalamic - pituitary relationships, e.g. vasopressin or ADH related
G01N2800/048 (Pituitary or hypothalamic - pituitary relationships) appears on 13 US grants and 21 published applications in this corpus.
Search patents in G01N- Granted patents
- 13
- Published applications
- 21
- Assignees
- 15
- Inventors
- 31
- Latest grant
- 16 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 2 | 5 |
| 2019 | 4 | 2 |
| 2020 | 2 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Optimizing mifepristone levels for Cushing's patients16 Nov 2021US 11,173,165 B2Corcept Therapeutics, Inc.
- Method for differentially diagnosing ACTH-dependent Cushing's syndrome27 Jul 2021US 11,073,523 B2Corcept Therapeutics, Inc.
- V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level8 Dec 2020US 10,857,129 B2B.R.A.H.M.S GmbH
- Optimizing mifepristone levels for cushing's patients26 May 2020US 10,660,904 B2Corcept Therapeutics, Inc.
- Method for differentially diagnosing ACTH-dependent Cushing's syndrome3 Dec 2019US 10,495,650 B2Corcept Therapeutics, Inc.
- Ratio between lta4h and metrnl in the assessment of polycystic ovarian syndrome5 Feb 2026US 2026/0036599 A1Roche Diagnostics Operations, Inc.
- Biomarker for diagnosing central precocious puberty in females and uses thereof29 Jan 2026US 2026/0029418 A1Affiliated Hospital of Nantong University
- Method for differentially diagnosing acth-dependent cushing's syndrome12 Oct 2023US 2023/0324415 A1Corcept Therapeutics, Inc.
- Kisspeptins to Predict and Treat Delayed Puberty6 Oct 2022US 2022/0313781 A1Children's Medical Center Corporation
- Reagent kit for detecting sex hormone and method for detecting sex hormone using same9 Jun 2022US 2022/0178952 A1Eone Reference Laboratory
Most cited
By later US patents
- Method for differentially diagnosing ACTH-dependent Cushing's syndrome26US 9,829,495 B2Corcept Therapeutics, Inc. · 2017
- Optimizing mifepristone levels for cushing's patients9US 9,943,526 B2Corcept Therapeutics, Inc. · 2018
- Optimizing mifepristone levels for Cushing's patients3US 10,166,242 B2Corcept Therapeutics, Inc. · 2019
- Optimizing mifepristone levels for cushing'S patients3US 10,166,243 B1Corcept Therapeutics, Inc. · 2019
- Method for differentially diagnosing ACTH-dependent cushing's syndrome2US 10,006,924 B2Corcept Therapeutics, Inc. · 2018